LOTTE Biologics Songdo Plant Receives G-SEED ‘Excellent’ Rating
LOTTE Biologics is strengthening its ESG competitiveness in the global biopharmaceutical contract development and manufacturing organization (CDMO) market, following recognition of the sustainable design and construction of Plant 1 at its Songdo Bio Campus. LOTTE Biologics announced that Plant 1 at the Songdo Bio Ca…
